Pifeltro manufacturer?

Who manufactures Pifeltro?

Pifeltro (doravirine) is an antiretroviral medication used to treat HIV-1 infection. It is manufactured by ViiV Healthcare, a global specialist in the field of HIV treatment.

What's unique about Pifeltro's development history?

Pifeltro was discovered by Shionogi & Co., Ltd. and was licensed to ViiV Healthcare for further development and commercialization.

How does Pifeltro compare with other HIV medications?

Pifeltro is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used in combination with other antiretroviral drugs to treat HIV-1 infection. It is not a combination product and is administered as a single pill once daily.

What patents and exclusivity rights protect Pifeltro?

According to DrugPatentWatch.com [1], Pifeltro's patent protection was set to expire in 2029, however ViiV Healthcare was able to extend this by 5 years. Check DrugPatentWatch.com for more information on patent expiration and exclusivity rights.

What support resources and programs are available for patients on Pifeltro?

Patients taking Pifeltro should discuss any concerns or questions with their healthcare provider or pharmacist. Additionally, the ViiV Healthcare website and other reputable health resources offer information and support for patients on Pifeltro.

Sources:

[1] DrugPatentWatch.com (Pifeltro patent information) - https://www.drugpatentwatch.com/patent/US10749219